CRISM Therapeutics Corporation (AIM:CRTX)
London · Delayed Price · Currency is GBP · Price in GBX 9.53
-0.22 (-2.26%)
Sep 25, 2026, 1:49 PM GMT
CRISM Therapeutics Market Cap
CRISM Therapeutics has a market cap or net worth of 7.72 million as of September 24, 2026. Its market cap has increased by 103.37% in one year.
Market Cap
7.72M
Enterprise Value
5.45M
Revenue
352.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
9.53
ChartMarket Cap Chart
Since March 15, 2006, CRISM Therapeutics's market cap has decreased from 28.23M to 7.72M, a decrease of -72.65%. That is a compound annual growth rate of -6.12%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 7.72M | 49.23% |
| Dec 31, 2025 | 5.17M | 43.93% |
| Dec 31, 2024 | 3.59M | -74.19% |
| Dec 30, 2022 | 13.93M | -40.80% |
| Dec 31, 2021 | 23.53M | 6.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oxford BioDynamics | 15.46M |
| Palatin Technologies | 14.56M |
| Fusion Antibodies | 14.08M |
| Aptamer Group | 11.23M |
| Genflow Biosciences | 10.90M |
| Solvonis Therapeutics | 7.83M |
| Cizzle Biotechnology Holdings | 6.37M |
| OptiBiotix Health | 6.15M |